These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 33031595)
1. Genetic polymorphism of liver X receptor gene in vitiligo: Does it have an association? Shehata WA; Maraee A; Mehesin M; Tayel N; Azmy R J Cosmet Dermatol; 2021 Jun; 20(6):1906-1914. PubMed ID: 33031595 [TBL] [Abstract][Full Text] [Related]
2. Liver X Receptor-α polymorphisms (rs11039155 and rs2279238) are associated with susceptibility to vitiligo. Agarwal S; Kaur G; Randhawa R; Mahajan V; Bansal R; Changotra H Meta Gene; 2016 Jun; 8():33-6. PubMed ID: 27014589 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor (VDR) gene polymorphism in Egyptian vitiligo patients. Saudi WM; Swelam MM; El-Barbary RAH; Zakaria L; Gaber DA J Cosmet Dermatol; 2021 Mar; 20(3):980-986. PubMed ID: 32648639 [TBL] [Abstract][Full Text] [Related]
4. The association between endothelin-1 gene polymorphisms and susceptibility to vitiligo in a Korean population. Kim HJ; Choi CP; Uhm YK; Kim YI; Lee JW; Yoon SH; Chung JH; Lee MH Exp Dermatol; 2007 Jul; 16(7):561-6. PubMed ID: 17576235 [TBL] [Abstract][Full Text] [Related]
5. Human beta-defensin 1 circulating level and gene polymorphism in non-segmental vitiligo Egyptian patients. Farag AGA; Shoeib MAA; Labeeb AZ; Sleem AS; Khallaf HMA; Khalifa AS; Elshaib ME; Elnaidany NF; Hanout HMA An Bras Dermatol; 2023; 98(2):181-188. PubMed ID: 36535830 [TBL] [Abstract][Full Text] [Related]
6. Inducible nitric oxide synthase promoter polymorphism: a molecular susceptibility marker for vitiligo in Egyptians. Zayed AA; Khorshied MM; Hussein MF Int J Dermatol; 2015 Jun; 54(6):675-9. PubMed ID: 25556582 [TBL] [Abstract][Full Text] [Related]
7. The association of functional polymorphisms in the aryl hydrocarbon receptor (AHR) gene with the risk of vitiligo in Han Chinese populations. Wang XW; Li K; Guo S; Qiang HN; Liu L; Song P; Wei C; Yi XL; Jian Z; Li Q; Li CY; Gao TW Br J Dermatol; 2012 May; 166(5):1081-7. PubMed ID: 22211302 [TBL] [Abstract][Full Text] [Related]
8. Concise review of recent studies in vitiligo. Allam M; Riad H Qatar Med J; 2013; 2013(2):1-19. PubMed ID: 25003059 [TBL] [Abstract][Full Text] [Related]
9. Is the +405 G/C single nucleotide polymorphism of the vascular endothelial growth factor (VEGF) gene associated with late-onset vitiligo? Almasi-Nasrabadi M; Amoli MM; Robati RM; Rajabi F; Parichehreh Dizaji S Int J Immunogenet; 2019 Aug; 46(4):241-246. PubMed ID: 31135085 [TBL] [Abstract][Full Text] [Related]
10. The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients. Ozel Turkcu U; Solak Tekin N; Gokdogan Edgunlu T; Karakas Celik S; Oner S Gene; 2014 Feb; 536(1):129-34. PubMed ID: 24333267 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor (TNF)-α- 308 G/A gene polymorphism (rs1800629) in Egyptian patients with alopecia areata and vitiligo, a laboratory and in silico analysis. Abd El-Raheem T; Mahmoud RH; Hefzy EM; Masoud M; Ismail R; Aboraia NMM PLoS One; 2020; 15(12):e0240221. PubMed ID: 33370782 [TBL] [Abstract][Full Text] [Related]
12. Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Gavalas NG; Akhtar S; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH Biochem Biophys Res Commun; 2006 Jul; 345(4):1586-91. PubMed ID: 16729966 [TBL] [Abstract][Full Text] [Related]
13. A case-control study on association of proteasome subunit beta 8 (PSMB8) and transporter associated with antigen processing 1 (TAP1) polymorphisms and their transcript levels in vitiligo from Gujarat. Jadeja SD; Mansuri MS; Singh M; Dwivedi M; Laddha NC; Begum R PLoS One; 2017; 12(7):e0180958. PubMed ID: 28700671 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo. Imran M; Laddha NC; Dwivedi M; Mansuri MS; Singh J; Rani R; Gokhale RS; Sharma VK; Marfatia YS; Begum R Br J Dermatol; 2012 Aug; 167(2):314-23. PubMed ID: 22512783 [TBL] [Abstract][Full Text] [Related]
15. Elevated X-Box Binding Protein1 Splicing and Interleukin-17A Expression Are Associated With Active Generalized Vitiligo in Gujarat Population. Jadeja SD; Vaishnav J; Bharti AH; Begum R Front Immunol; 2021; 12():801724. PubMed ID: 35046957 [TBL] [Abstract][Full Text] [Related]
16. No association between catalase (CAT) gene polymorphisms and susceptibility to vitiligo in a Turkish population. Akbas H; Dertlioglu SB; Dilmec F; Balkan M Clin Ter; 2013; 164(3):e173-7. PubMed ID: 23868633 [TBL] [Abstract][Full Text] [Related]
17. CDH1 and DDR1 common variants confer risk to vitiligo and autoimmune comorbidities. Almasi-Nasrabadi M; Amoli MM; Robati RM; Rajabi F; Ghalamkarpour F; Gauthier Y Gene; 2019 Jun; 700():17-22. PubMed ID: 30890477 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the correlation between serum levels of vitamin D and vitamin D receptor gene polymorphisms in an Egyptian population. Sobeih S; Mashaly HM; Gawdat H; Amr K; Hamid MF; Shaalan E Int J Dermatol; 2016 Dec; 55(12):1329-1335. PubMed ID: 27420410 [TBL] [Abstract][Full Text] [Related]
19. Association of genetic variants of the vitamin D receptor gene with vitiligo in a tertiary care center in a Saudi population: a case-control study. Saif GB; Khan IA Ann Saudi Med; 2022; 42(2):96-106. PubMed ID: 35380061 [TBL] [Abstract][Full Text] [Related]
20. Association of elevated homocysteine levels and Methylenetetrahydrofolate reductase (MTHFR) 1298 A > C polymorphism with Vitiligo susceptibility in Gujarat. Jadeja SD; Mansuri MS; Singh M; Patel H; Marfatia YS; Begum R J Dermatol Sci; 2018 May; 90(2):112-122. PubMed ID: 29395581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]